EUVIMEDEUVIMED entdecken
Crossref

MUSASHI1 promotes tau phosphorylation by activating the p38 MAPK pathway

Wenshuang Li, Baomiao Ma, Xiang Tian, Qi Xiong, Mengqi Zhou, Wei Liu, Xiji Shu

Neurochemistry International · 2025

DOI: 10.1016/j.neuint.2025.106066 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neurochemistry International, 2025. Verfasst von Wenshuang Li und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, Jianghan University, 430056, Wuhan, China; Hubei Key Laboratory of Cognitive and Affective Disorders, Jianghan University, 430056…. Hauptthemen laut MEDLINE: tau Proteins, RNA-Binding Proteins, Nerve Tissue Proteins, p38 Mitogen-Activated Protein Kinases. Die Arbeit nennt 33 Literaturangaben. Gefördert von: Wuhan Science and Technology Project, Jianghan University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aberrant phosphorylation of the Tau protein represents a critical event in the pathogenesis of Alzheimer's disease (AD); however, therapeutic interventions specifically targeting this modification remain limited. Therefore, a thorough understanding of the molecular mechanisms underlying Tau hyperphosphorylation is essential for the development of effective preventive and therapeutic strategies against AD. The RNA-binding protein MUSASHI1 (MSI1) is recognized for its significant role in neurodevelopment, and previous studies have reported its dysregulated overexpression in the brains of AD patients. In the current investigation, we demonstrate that MSI1 expression progressively increases in parallel with the advancement of Tau pathology in P301S transgenic mouse models. Furthermore, our findings suggest that MSI1 activates the p38 mitogen-activated protein kinase (MAPK) signaling pathway, thereby promoting Tau phosphorylation. Additionally, we have identified two microtubule-associated proteins as novel potential interaction partners of MSI1 within neuronal cells. Collectively, these results reveal a previously uncharacterized mechanism that may contribute to aberrant Tau phosphorylation in AD, offering new directions for future research in this field.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

tau ProteinsRNA-Binding ProteinsNerve Tissue Proteinsp38 Mitogen-Activated Protein KinasesMAP Kinase Signaling SystemPhosphorylationAnimalsMice, TransgenicMiceHumansAlzheimer DiseaseMice, Inbred C57BL

Stichwörter der Autor:innen

Alzheimer's disease (AD)PhosphorylationRNA-Binding protein MUSASHI1 (MSI1)Taup38 MAPK

Substanzen

tau ProteinsRNA-Binding ProteinsNerve Tissue Proteinsp38 Mitogen-Activated Protein KinasesMsi1h protein, mouseMSI1 protein, human

Autor:innen und Institutionen

  • School of Medicine, Jianghan University, 430056, Wuhan, China; Hubei Key Laboratory of Cognitive and Affective Disorders, Jianghan University, 430056 Wuhan, China; Hubei Provincial Demonstration Center for Experimental…

Förderung

  • Wuhan Science and Technology Project
  • Jianghan University

Zitieren

APA

Li, W., Ma, B., Tian, X., Xiong, Q., Zhou, M., Liu, W., & Shu, X. (2025). MUSASHI1 promotes tau phosphorylation by activating the p38 MAPK pathway. Neurochemistry International. https://doi.org/10.1016/j.neuint.2025.106066

Vancouver

Li W, Ma B, Tian X, Xiong Q, Zhou M, Liu W, et al. MUSASHI1 promotes tau phosphorylation by activating the p38 MAPK pathway. Neurochemistry International. 2025. doi:10.1016/j.neuint.2025.106066

BibTeX
@article{Li2025,
  author = {Li, Wenshuang and Ma, Baomiao and Tian, Xiang and Xiong, Qi and Zhou, Mengqi and Liu, Wei and Shu, Xiji},
  title = {MUSASHI1 promotes tau phosphorylation by activating the p38 MAPK pathway},
  journal = {Neurochemistry International},
  year = {2025},
  doi = {10.1016/j.neuint.2025.106066}
}
Kostenlos starten →